Back to STATE STREET CORP STATE STREET CORP

ALLOALLO
Showing 8 of 28 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ALLOGENE THERAPEUTICS INC

STATE STREET CORP holds 19M shares of ALLO (ALLOGENE THERAPEUTICS INC), worth $39.6M as of 2026-Q2. The position was increased (+119.7% shares). ALLO represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$39.6M

Current Shares

19M

Total Value Change

+$19.9M

Total Shares Change

+12M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
19M
+119.7%
$39.6M0.0%$2.08
47
2026-Q1
Increased
8.7M
+213.6%
$21.1M0.0%$2.44
46
2025-Q4
Increased
2.8M
+0.2%
$3.8M0.0%$1.37
27
2025-Q3
Increased
2.8M
+1.2%
$3.4M0.0%$1.24
27
2025-Q2
Decreased
2.7M
-2.4%
$3.1M0.0%$1.13
0
2025-Q1
Decreased
2.8M
-61.5%
$4.1M0.0%$1.46
0
2024-Q4
Increased
7.2M
+3.4%
$15.4M0.0%$2.13
29
2024-Q3
Decreased
7M
-8.5%
$19.6M0.0%$2.80
0

Other major holders of ALLO: TPG Group Holdings (SBS) Advisors, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used